Citations to this article

Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.
W H Raskind, … , J W Adamson, P J Fialkow
W H Raskind, … , J W Adamson, P J Fialkow
Published April 1, 1985
Citation Information: J Clin Invest. 1985;75(4):1388-1390. https://doi.org/10.1172/JCI111840.
View: Text | PDF
Research Article

Evidence for the involvement of B lymphoid cells in polycythemia vera and essential thrombocythemia.

Abstract

Previous studies with the X-chromosome-linked glucose-6-phosphate dehydrogenase (G6PD) as a marker of cellular mosaicism demonstrated that polycythemia vera (PV) and essential thrombocythemia (ET) are clonal disorders of hematopoietic stem cells that can differentiate to erythrocytes, granulocytes, and platelets. To determine if the involved stem cells could also differentiate along the B-lymphoid pathway, we studied one woman with PV and one woman with ET. Of 117 Epstein-Barr virus-transformed B-lymphoblastoid lines expressing a single G6PD derived from the patient with PV, 108 expressed G6PD type A, the type characteristic of the abnormal clone. The ratio of 108:9 was significantly different from the one to one ratio predicted for this patient, which suggested that at least some circulating progenitors for B-lymphoid cell lines differentiate from the stem cell involved by the disease. Results obtained from the patient with ET were similar--104 of the 109 lymphoblastoid lines monotypic for G6PD expression displayed the enzyme type found in the abnormal clone of marrow cells. Therefore, in these patients, PV and ET, like chronic myelogenous leukemia, involve a stem cell pluripotent for the lymphoid as well as the myeloid series.

Authors

W H Raskind, R Jacobson, S Murphy, J W Adamson, P J Fialkow

×

Total citations by year

Year: 2023 2022 2017 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1992 1991 1990 1989 1988 1987 Total
Citations: 1 1 1 1 1 1 1 4 1 2 2 4 4 1 3 4 2 3 2 1 3 5 2 3 5 2 1 2 2 1 1 67
Citation information

Citations to this article (67)

Title and authors Publication Year
A Rare Coexistence of Multiple Myeloma and Polycythemia Vera.
Landsman A, Barua P, Podrumar A 		Journal of Hematology 2023
Development of multiple myeloma after 15 years of treatment for polycythemia vera and successful treatment using bortezomib: A case report.
Kimura H, Furukawa M, Mori H, Shiga Y, Asai J, Satoh K, Kai T 		Clinical Case Reports 2022
CALR-positive myeloproliferative disorder in a patient with Ph-positive chronic myeloid leukemia in durable treatment-free remission: a case report
I Dogliotti, C Fava, A Serra, E Gottardi, F Daraio, F Carnuccio, E Giugliano, M Bocchia, G Saglio, G Rege-Cambrin 		Stem Cell Investigation 2017
Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells
J Bullerdiek, D Gisselsson 		Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells 2015
Myeloproliferative Disorders
B Meier, JH Burton 		Emergency Medicine Clinics of North America 2014
MPN patients harbor recurrent truncating mutations in transcription factor NF-E2
JS Jutzi, R Bogeska, G Nikoloski, CA Schmid, TS Seeger, F Stegelmann, S Schwemmers, A Grunder, JC Peeken, M Gothwal, J Wehrle, K Aumann, K Hamdi, C Dierks, W Wang, K Dohner, JH Jansen, HL Pahl 		Journal of Experimental Medicine 2013
No Evidence for JAK2V617F Mutation in Monoclonal B Cells in 2 Patients with Polycythaemia Vera and Concurrent Monoclonal B Cell Disorder
C Stijnis, WG Kroes, S Balkassmi, EW Marijt, AP Rossum, E Bakker, LT Vlasveld 		Acta Haematologica 2012
Mutations with epigenetic effects in myeloproliferative neoplasms and recent progress in treatment: Proceedings from the 5th International Post-ASH Symposium
A Tefferi, O Abdel-Wahab, F Cervantes, JD Crispino, G Finazzi, F Girodon, H Gisslinger, J Gotlib, JJ Kiladjian, RL Levine, JD Licht, A Mullally, O Odenike, A Pardanani, RT Silver, E Solary, T Mughal 		Blood Cancer Journal 2011
Essential Thrombocythemia and Multiple Myeloma: Two Rare Diseases in One Patient
AE Eskazan, S Ongoren, MC Ar, T Soysal, B Ferhanoglu, H Aki, Y Aydin 		Clinical Lymphoma Myeloma and Leukemia 2011
Advances in Cancer Research
M Lemaire, S Deleu, ED Bruyne, EV Valckenborgh, E Menu, K Vanderkerken 		Advances in Cancer Research Volume 110 2011
Coexistence of Plasma Cell Dyscrasia with Prefibrotic Stage of Primary Myelofibrosis: A Case Report
G Tsirakis, P Kanellou, M Kaparou, A Passam, A Zampoulaki, K Stylianou, MG Alexandrakis 		ISRN Hematology 2011
Cancer Cytogenetics
J Bullerdiek, D Gisselsson 		Cancer Cytogenetics 2010
Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?
P Tabaczewski, S Nadesan, SH Lim 		Leukemia Research 2009
Involvement of mast cells by the malignant process in patients with Philadelphia chromosome negative myeloproliferative neoplasms
J Wang, T Ishii, W Zhang, S Sozer, Y Dai, J Mascarenhas, V Najfeld, ZJ Zhao, R Hoffman, N Wisch, M Xu 		Leukemia 2009
The JAK2V617F Mutation in Polycythemia Vera and Other Myeloproliferative Disorders: One Mutation for Three Diseases?
C James 		Hematology 2008
Abeloff's Clinical Oncology
ER Fearon, GT Bommer 		Abeloff's Clinical Oncology 2008
The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders
TS Larsen, JH Christensen, HC Hasselbalch, N Pallisgaard 		British Journal of Haematology 2007
JAK-2 mutations and their relevance to myeloproliferative disease
RL Levine, DG Gilliland 		Current Opinion in Hematology 2007
T cells from patients with polycythemia vera elaborate growth factors which contribute to endogenous erythroid and megakaryocyte colony formation
T Ishii, Y Zhao, J Shi, S Sozer, R Hoffman, M Xu 		Leukemia 2007
The history of myeloproliferative disorders: before and after Dameshek
A Tefferi 		Leukemia 2007
Chronic neutrophilic leukemia and chronic myelomonocytic leukemia: WHO defined
MA MD 		Best Practice & Research Clinical Haematology 2006
Classification of chronic myeloid disorders: From Dameshek towards a semi-molecular system
A Tefferi, G Gilliland 		Best Practice & Research Clinical Haematology 2006
Thrombocytémie essentielle. Critères du diagnostic. Stratification pronostique. Ébauche de stratégie thérapeutique
J Brière 		EMC - Hematologie 2006
Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera
T Ishii, E Bruno, R Hoffman, M Xu 		Blood 2006
The JAK2V617F Tyrosine Kinase Mutation in Myeloproliferative Disorders: Status Report and Immediate Implications for Disease Classification and Diagnosis
A Tefferi, DG Gilliland 		Mayo Clinic Proceedings 2005
Propensity for hemorrhage and thrombosis in chronic myeloproliferative disorders
CM Kessler 		Seminars in Hematology 2004
The chronic myeloproliferative disorders: Clonality and clinical heterogeneity
JL Spivak 		Seminars in Hematology 2004
Molecular markers for the diagnosis of Philadelphia chromosome negative myeloproliferative disorders
S Klippel, HL Pahl 		Pathologie Biologie 2004
Polycythemia vera
NI Berlin 		Hematology/Oncology Clinics of North America 2003
Polycythemia Vera: A Comprehensive Review and Clinical Recommendations
A Tefferi 		Mayo Clinic Proceedings 2003
Molecular Markers in Myeloproliferative Disorders: From Classification to Prognosis?
HL Pahl 		Hematology 2003
Both B and T lymphocytes may be clonally involved in myelofibrosis with myeloid metaplasia
TL Reeder, RJ Bailey, GW Dewald, A Tefferi 		Blood 2003
Exploring polycythaemia vera with fluorescence in situ hybridization: additional cryptic 9p is the most frequent abnormality detected*
V Najfeld, L Montella, A Scalise, S Fruchtman 		British Journal of Haematology 2002
Leukemogenic Risk of Hydroxyurea Therapy as a Single Agent in Polycythemia Vera and Essential Thrombocythemia: N-and K-ras Mutations and Microsatellite Instability in Chromosomes 5 and 7 in 69 Patients
D Mavrogianni, N Viniou, E Michali, E Terpos, J Meletis, G Vaiopoulos, M Madzourani, G Pangalis, X Yataganas, D Loukopoulos 		International Journal of Hematology 2002
The Pathogenesis of Chronic Myeloproliferative Diseases
A Tefferi 		International Journal of Hematology 2001
Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management
A Tefferi, S Murphy 		Blood Reviews 2001
Recent progress in the pathogenesis and management of essential thrombocythemia
A Tefferi 		Leukemia Research 2001
Platelets
JN George 		The Lancet 2000
Towards a molecular understanding of polycythemia rubra vera
HL Pahl 		European Journal of Biochemistry 2000
Acute Lymphoid Leukemia Following Polycythemia Vera
M Camós, F Cervantes, S Montoto, JC HernáNdez-Boluda, N Villamor, E Montserrat 		Leukemia & Lymphoma 1999
Impaired Platelet Binding of Fibrinogen Due to a Lower Number of GPIIB/IIIA Receptors in Polycythemia Vera
KL Blanc, T Lindahl, K Rosendahl, J Samuelsson 		Thrombosis Research 1998
5 Clonality markers in polycythaemia and primary thrombocythaemia
J Briere, N El-Kassar 		Baillière's Clinical Haematology 1998
Clonality Analysis of Hematopoiesis and Thrombopoietin Levels in Patients with Essential Thrombocythemia
N El-Kassar, G Hetet, J Brière, B Grandchamp 		Leukemia & Lymphoma 1998
Defective Neutrophil Oxidative Metabolism in Polycythemia Vera Is Associated with an Impaired Activation of Phospholipase D
J Samuelsson, J Palmblad 		Annals of the New York Academy of Sciences 1997
4 Megakaryocytes and platelets in myeloproliferative disorders
J Briere, JJ Kiladjian, E Peynaud-Debayle 		Baillière's Clinical Haematology 1997
Pathogenesis of polycythaemia vera
S Hinshelwood, AJ Bench, AR Green 		Blood Reviews 1997
No evidence for an altered mRNA expression or protein level of haematopoietic cell phosphatase in CD34+ bone marrow progenitor cells or mature peripheral blood cells in polycythaemia vera
P Andersson, K LeBlanc, BÅ Eriksson, J Samuelsson 		European Journal of Haematology 1997
Clonality Analysis of Hematopoiesis in Essential Thrombocythemia: Advantages of Studying T Lymphocytes and Platelets
N El-Kassar, G Hetet, J Brière, B Grandchamp 		Blood 1997
Clonality Assays and Megakaryocyte Culture Techniques in Essential Thrombocythemia
L Yan, N Elkassar, C Gardin, J Briere 		Leukemia & Lymphoma 1996
Malignome und Hämostase
E Spanuth 		1996
Characterization of 20q deletions in patients with myeloproliferative disorders or myelodysplastic syndromes
E Nacheva, T Holloway, N Carter, C Grace, N White, AR Green 		Cancer Genetics and Cytogenetics 1995
Impaired Activation of Phospholipase D in Polycythaemia Vera-Implications for the Pathogenesis of the Disease?
J Samuelsson 		Leukemia & Lymphoma 1995
Multiple Myeloma Following Essential Thrombocythemia
F Cobo, F Cervantes, C Martinez, C Salgado, J Blade, E Montserrat, C Rozman 		Leukemia & Lymphoma 1995
Polycythaemia vera. III. Burst-forming units-erythroid (BFU-E) response to stem cell factor and c-kit receptor expression
CH Dai, SB Krantz, WF Green, HS Gilbert 		British Journal of Haematology 1994
Clonality in chronic myeloproliferative disorders defined by X-chromosome linked probes: demonstration of heterogeneity in lineage involvement
N Tsukamoto, K Morita, T Maehara, K Okamoto, H Sakai, M Karasawa, T Naruse, M Omine 		British Journal of Haematology 1994
Studies of neutrophil and monocyte oxidative responses in polycythaemia vera and related myeloproliferative disorders
J Samuelsson, J Forslid, J Hed, J Palmblad 		British Journal of Haematology 1994
Stimulus-specific defect in platelet aggregation in polycythemia vera
KL Blanc, A Berg, J Palmblad, J Samuelsson 		European Journal of Haematology 1994
Issues in the Diagnosis and Management of Essential Thrombocythemia
A Tefferi, HC Hoagland 		Mayo Clinic Proceedings 1994
Coexistence of essential thrombocythemia and multiple myeloma
F Prósper, JR Borbolla, J Rifón, B Cuesta, J Fernández, A Pinacho, E Rocha 		Annals of Hematology 1992
Clonality in Myeloproliferative Disorders
KL Blanchard, DG Gilliland, HF Bunn 		The American Journal of the Medical Sciences 1992
Chromosome Studies in 104 Patients With Polycythemia Vera
JL Diez-Martin, DL Graham, RM Petitt, GW Dewald 		Mayo Clinic Proceedings 1991
Essential Thrombocythemia in a Cat
AS Hammer, CG Couto, D Getzy, MQ Bailey 		Journal of Veterinary Internal Medicine 1990
New Approaches to the Treatment of Leukemia
AM Marmont, EA McCulloch, JK Rees, P Reizenstein, PH Wiernik, EJ Freireich 		1990
Polycythemia: Evaluation and management
WG Hocking, DW Golde 		Blood Reviews 1989
The application of X-chromosome gene probes to the diagnosis of myeloproliferative disease
GS Lucas, RA Padua, GS Masters, DG Oscier, A Jacobs 		British Journal of Haematology 1989
Acute lymphoblastic leukemia in a patient with longstanding polycythemia vera: Cytogenetic analysis reveals two distinct abnormal clones
J Anastasi, MJ Pettenati, MM le Beau, HC Kwaan, SC Weil 		American Journal of Hematology 1988
Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia
S Eridani, B Sawyer, TC Pearson 		European Journal of Haematology 1987

Advertisement